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a b s t r a c t
Baby Boomers (BBs) are responsible for three-quarters of hepatitis C virus (HCV) infections in the United
States; however, HCV testing is distinctly underused by them. A cross-sectional study was conducted to
assess the prevalence of HCV testing and to evaluate predictors of HCV testing intention among African–
American BBs. The study was guided by the Health Belief Model and theory of reasoned action frame-
works. Of the 137 participants included in the study, 44.8% had at least a college education; 13.9%
received prior to 1992 blood transfusion. Findings related to HCV testing showed that 32.1% of the par-
ticipants intended to test for HCV within 6 months and 43.8% had received a previous HCV test.
Significant predictors of HCV testing intention within 6 months included having a blood transfusion prior
to 1992 [odds ratio (OR) = 8.25, 95% confidence interval (CI): 2.02–33.61], perceptions of benefits
(OR = 1.57, 95% CI: 1.13–2.18), severity (OR = 1.39, 95% CI: 1.17–1.65), and subjective norms (OR = 1.42,
95% CI: 1.12–1.79). These predictors of HCV testing intention can be used to develop future HCV testing
initiatives for African–American BBs.
 2017 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Hepatitis C virus (HCV) infection started as an epidemic
between the 1960s and 1980s [1]. The World Health Organization
estimates that >170 million people are living with HCV worldwide
[2]. This infection is a primary public health concern among
4 million people infected with HCV in the United States; particu-
larly among people born between 1945 and 1965, for whom this is
the main blood borne infection [1,3,4]. This population subgroup,
commonly known as Baby Boomers (BBs), has five times the risk
of HCV than other groups [5].
Encouraging testing and treatment for BBs is critical. However,
these efforts have been challenging because BBs are mostly una-
ware of their HCV vulnerability and status [6]. Evidence suggests
underuse of HCV testing services, despite the earlier promotion
of testing by the United States Centers for Disease Control and
Prevention (CDC) in 1998 [7]. Recently updated recommendations
from the CDC published in August 2012 emphasize that all BBs
should have a one-time HCV test to prevent adverse health
consequences [5]. Given the evidence of a low perception of
susceptibility to HCV [6], it is important to examine whether this
is a predictor of intention to test for it in this population.
A review of the literature review has shown a scarcity of
theory-based research examining factors that predict or explain
the willingness of BBs to have an HCV test. Specifically, the effects
of variables related to the behavioral theories, such as knowledge
perceptions, cues to action, and subjective norms [8,9], on inten-
tion to test for HCV have not been well investigated. Lack of such
theory-driven HCV testing studies among African–American (AA)
BBs is also evident in the literature. Given that sociodemographic
and psychosocial factors determine health-seeking behaviors, it
would be significant to understand which of these factors affect
intention to test for HCV among AABBs.
The Health Belief Model (HBM) and the theory of reasoned
action (TRA) include several psychosocial constructs that can be
used to model preventive seeking behavior [10,11]; however, few
studies have used them to evaluate HCV testing behavior. The pur-
pose of this study was to assess the prevalence of HCV testing and
to determine whether HBM/TRA constructs, prior HCV testing and
other sociodemographic characteristics predict intention to testing
for HCV among AABBs. We were particularly interested in testing
whether the perception of susceptibility would affect intention to
test for HCV.
http://dx.doi.org/10.1016/j.jegh.2016.12.005
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2. Participants and methods
2.1. Study design and population
The study had a cross-sectional design and included a conve-
nience sample of 137 persons. The study started on February 1,
2014 and continued to March 30, 2014. Respondents recruited
were AAs residing in Washington DC area, aged 44–69 years, and
who were visiting or receiving service at Howard University Hospi-
tal and Ms. Bernice Elizabeth Fonteneau Senior Wellness Center in
Washington DC. Respondents who were incapable of using the
audio computer-assisted self-interview (ACASI) system were
excluded from the study. A gift card for 10 US dollars was provided
as an incentive. This study was approved by the Howard University
Institutional Review Board.
2.2. Sample size calculation
A total of 137 participants were included in the study; 80 of
them were recruited from Howard University Hospital and the
remaining 57 were from Ms. Bernice Elizabeth Fonteneau Senior
Wellness Center. This sample size was sufficient and had 80%
power to test the primary hypothesis based on a multiple logistic
regression analysis assuming a = 0.05; an assumed odds ratio and
R2 of 2.96 and 0.20, respectively. These assumptions were based
on previous studies that have utilized the HBM model.
2.3. Data collection
The interviews were conducted using ACASI with an instrument
developed specifically for this study. The instrument used in this
study was created from previously used questionnaires by Poss
et al. [12], which provided items for assessment of HBM/TRA con-
structs and from Lindsay et al. [13] and Proeschold et al. [14], who
offered items relevant for the evaluation of HCV knowledge. Items
to collect sociodemographic and prior HCV testing history were
also added. The survey items were modified to suit our study pop-
ulation and subject matter and retested for reliability in a separate
pilot study before the start of this study. After informed consent
had been provided, data collection was done in a designated area
at the recruitment sites under the oversight of study personnel.
2.4. Statistical analysis
Descriptive statistics were estimated for the primary outcome
HCV testing intention within 6 months, along with other study
variables (i.e., demographics, prior testing history, HBM and TRA
constructs, and HCV knowledge). Means and standard deviations
were used for continuous variables while frequencies and propor-
tions were used for categorical variables. A logistic regression anal-
ysis was conducted to examine factors that predict willingness to
test for HCV within 6 months. Both simple and multiple logistic
regressions were performed. Covariate selection into the final mul-
tivariable model was based on whether the variable met the crite-
ria of p < 0.2 in the simple logistic regression or whether it was of
theoretical/clinical importance in the study. The variables assessed
included HBM constructs, TRA construct of subjective norms, age,
marital status, income, gender, education, previous HCV testing,
health insurance, having a blood transfusion prior to 1992 and
HCV knowledge. Adjusted and unadjusted odds ratios (ORs) with
their 95% confidence intervals (CIs) were estimated and reported.
Based on literature findings, interaction testing was also conducted
to evaluate possible effect modification of the effect of perceived
susceptibility (an HBM construct) and subjective norms (TRA
construct). All analyses were performed using SPSS version 22 at
an a value of 0.05.
3. Results
3.1. Patient characteristics
Of the 137 participants, 60.6% were female, and 44.8% had at
least a college education. The mean age of respondents was
58.85 years. An estimated 43.8% of AABBs had a previous HCV test;
11 of whom were HCV positive while 32.1% of respondents had the
intention to test for HCV within 6 months. About 68% did not con-
sider themselves susceptible to HCV as AABBs and 72.3% as BBs.
Other characteristics are summarized in Table 1.
3.2. Predictors of intention to test for HCV within 6 months
Table 2 shows results of the logistic regression analysis model-
ing intention to test for HCV within 6 months. Findings from the
adjusted analysis showed that age, prior blood transfusion, subjec-
tive norms, perceived severity, and perceived benefits were statis-
tically significant adjusted predictors of intention to test for HCV
within 6 months. The model v2 was 54.24 (degrees of free-
dom = 10, p  0.0001), and the Hosmer–Lemeshow test was not
significant (p = 0.347) indicating good model fit. Nagelkerke R2
was 0.329, which means that 32.9% variability in intention to test
for HCV within 6 months is explained by the variables included in
the model.
Table 2 shows that age had an inverse relationship with inten-
tion to test for HCV within 6 months. A 1-year increase in age was
associated with a decrease in the odds of having an HCV test
Table 1
Sociodemographic and health-related characteristics of respondents.
Sociodemographic characteristics Findings
Age 58.85 ± 6.38





No school/grades 1–11 16 (11.80)
High school 59 (43.40)
College degree 35 (25.70)
Graduate degree 26 (19.10)
Prior to 1992 received a blood transfusion or blood products
Yes 19 (13.90)
No/unsure 118 (86.20)
Susceptible to HCV as African American
Yes 44 (32.10)
No 93 (67.90)
Susceptible to HCV as Baby Boomer
Yes 38 (27.70)
No 99 (72.30)
Prior test for hepatitis C
Yes 60 (43.80)
No 77 (56.20)







Intention to test for HCV within next 6 months
Yes 44 (32.10)
No 93 (67.90)
Data are presented as mean ± standard deviation or n (%).
HCV = hepatitis C virus.
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(OR = 0.90, 95% CI: 0.82–0.98). Participants who had blood transfu-
sion prior to 1992 had eight times the odds of intending to test for
HCV within 6 months compared to those who did not have a prior
blood transfusion (OR = 8.25, 95% CI: 2.02–33.61). Increased odds
of intention to test for HCV within 6 months was also observed
for those with higher subjective norms scores (OR = 1.42, 95% CI:
1.12–1.79), perceived severity scores (OR = 1.39, 95% CI: 1.17–
1.65), and perceived benefit scores (OR = 1.57, 95% CI: 1.13–2.18).
There was no effect of perceived susceptibility on intention to test
for HCV within 6 months. Possible interaction between susceptibil-
ity and subjective norms was evaluated, and no interaction effect
was found.
4. Discussion
This study sought to assess the prevalence of HCV testing and to
determine factors associated with HCV testing among AABBs. To
the best of our knowledge, this is one of the first studies to assess
HCV testing intentions in this population. Our findings show evi-
dence of low HCV testing intention among AABBs, with only
32.1% of the participants reporting intention to have an HCV test
within 6 months. Based on BBs being a high-risk group, these find-
ings of HCV testing intention are suggestive but not confirmatory
for low future testing rates among AABBs, as intentions are not
representative of actual testing behavior. However, the 43.8% prior
HCV testing rate observed shows evidence of low HCV testing rates
and substantiates earlier data showing that nearly 83% of BBs do
not perceive themselves to be at risk [6]. As most of the studies
on intention to test for HCV have been among populations of drug
users [15–18], comparison with our estimates are challenging and
further studies to confirm our findings are needed. In the mean-
time, HCV testing educational programs among AABBs would
improve their awareness and HCV testing.
As expected participants who reported having a blood transfu-
sion prior to 1992 were more likely to intend to test for HCV within
6 months than those who did not (OR = 8.25, 95% CI: 2.02–33.61).
No comparative studies were available to confirm our findings;
however, a possible explanation for these results is that people
who had transfusions prior to 1992 would have higher perceptions
of risk perhaps from information gathered from public health mes-
sages on the potential for contaminated blood during that period,
leading them to have a greater intention to test. More studies
can be done to see if these findings can be replicated in other
studies.
Subjective norms score was found to be a significant predictor
of intention to test for HCV among AABBs. Specifically, those with
higher scores on subjective norms were more likely to have the
intention to test for HCV within 6 months (OR = 1.42, 95% CI:
1.12–1.79). A possible explanation for these findings could be the
culture of collectivism within the AA community. Existing litera-
ture supports that one of the main cultural values accredited to
AAs is collectivism [19–23]. In collective cultures, interdependence
levels between individuals and willingness to be affected by others
are both high. Since subjective norms were a significant predictor
of intention to test for HCV, using community-based approaches
that use respected family or valued peers may work best to
increase awareness of HCV and subsequent testing.
Respondents with more perceived severity of HCV infection
(OR = 1.39, 95% CI: 1.17–1.65) were more likely to have intention
to test for HCV, while the perceived impact of susceptibility on
intention to test, our primary hypothesis, was not a significant pre-
dictor in the adjusted model. Null findings from our primary
hypothesis were contrary to studies that have looked at how per-
ceived susceptibility affects other screening behavior, such as col-
orectal cancer screening within this population [24]. Findings
related to severity also were unexpected since this construct has
been identified to have weak relationships with preventive behav-
ior in general [25]. Collectively, it is plausible that perception of
severity, rather than vulnerability to infection would be a motiva-
tor for HCV testing for this population; however, further studies
are needed to confirm this effect.
Our study was not without limitations. First, the study design
was cross-sectional in nature, thus no causal inferences can be
made. A convenient sampling was used in this study; thus, the
recruited sample may not be generalized to AABBs in Washington
Table 2
Predictors of HCV testing intention within 6 months.
Characteristic ORunadjusted (95%CI) punadjusted ORadjusted (95%CI) padjusted
Age 0.91 (0.86, 0.97) 0.004 0.90 (0.82, 0.98) 0.011*
Male REF REF REF REF
Female 0.46 (0.22, 0.95) 0.036 0.47 (0.18, 1.22) 0.119
No prior transfusion REF REF REF REF
Prior transfusion 1.58 (0.77, 3.26) 0.013 8.25 (2.02, 33.61) 0.003*
No prior HCV test REF REF REF REF
Prior HCV test 1.11 (0.79, 1.56) 0.083 1.34 (0.49, 3.70) 0.575
Cues to actiona 1.04 (0.38, 2.85) 0.372 0.28 (0.08, 1.07) 0.063
Perceived barriersb 0.98 (0.84, 1.14) 0.328 0.93 (0.83, 1.05) 0.268
Subjective normsc 3.54 (1.31, 9.58) 0.001 1.42 (1.12, 1.79) 0.003*
Perceived susceptibilityd 1.90 (0.92, 3.93) 0.042 0.94 (0.81, 1.09) 0.381
Perceived severitye 1.47 (0.63, 3.43) 0.003 1.39 (1.17, 1.65) 0.008*
Perceived benefitsf 1.04 (0.96, 1.12) 0.082 1.57 (1.13, 2.18) 0.015*
Knowledgeg 1.32 (1.12, 1.56) 0.046 1.10 (0.87, 1.40) 0.409
Wellness center REF REF REF REF
Howard hospital 0.725 (0.346, 1.52) 0.392 0.603 (0.227, 1.60) 0.143
Perceived barriers 0.98 (0.84, 1.14) 0.328 0.93 (0.83, 1.05) 0.268
R2 = 0.32; *p < 0.05.
CI = confidence interval; HCV = hepatitis C virus; OR = odds ratio.
a Any strategies motivating willingness to test.
b Barriers that prevent patient from having a test.
c Perceived social impact on readiness to have a test.
d Perception of acquiring the disease.
e Patient perception of disease severity.
f Belief in the effectiveness of the test in risk reduction.
g Knowledge of respondents regarding HCV.
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DC. Second, this study did not follow up to identify testing
behavior; instead, we relied on intention to test for HCV within
6 months as a proxy for actual behavior. Third, all items in the
study were based on self-report. As such, this study may have been
prone to some social desirability bias. Particular items with poten-
tial for reporting bias could have been those related to prior HCV
testing and results; however, this effect may have been minimized
by our use of the ACASI method during data collection. Lastly, our
study was conducted in the Washington DC region. Further evalu-
ation must be carried out in different geographical areas to confirm
these findings for other AABBs. Despite these limitations, our study
adds new knowledge on the prevalence and predictors of HCV test-
ing intention in this high-risk group.
5. Conclusion
Low rates of intention to test for HCV as well as prior HCV test-
ing history observed in this study point to the need to develop
screening and education programs for AABBs. Such screening pro-
grams can focus on alerting AABBs on the severity as well as the
potential benefits of testing. Findings on subjective norms indicate
that community approaches involving family, or valued peers may
assist in the acceptance of such programs. Further studies to con-
firm our findings in other similar populations are recommended.
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